AGF Management’s Insmed INSM Stock Holding History

AGF Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.4M	Sell	57,458 -1,377	-2%	-$212K	0.04%	207
2025 Q4	$10.2M	Buy	+58,835	New	+$10.7M	0.04%	206

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

AGF Management's INSM Position: Q1 2026 in Review

AGF Management reduced its Insmed (INSM) stake by 2.3% in Q1 2026, selling an estimated $212K and leaving 57,458 shares worth $9.4M. The position accounts for 0.04% of the portfolio, ranked #207.

AGF Management first reported a position in INSM in Q4 2025 and has held it in 2 quarters since. The position peaked at $10.2M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

AGF Management held 57,458 shares of Insmed worth $9.4M as of Q1 2026.
AGF Management sold 1,377 Insmed shares in Q1 2026, an estimated $212K.
Insmed made up 0.04% of AGF Management's portfolio in Q1 2026, its #207 holding.
AGF Management first reported a position in Insmed in Q4 2025 and has held it in 2 quarters since.
AGF Management's Insmed position peaked at $10.2M in Q4 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on AGF Management's 13F filing for Q1 2026, filed 7 May 2026.